Fexofenadine Suspension Franchise in Ahmedabad

Anti Allergic Syrup Supplier in Mumbai

Fexofenadine Suspension Distributor in Delhi

Allergy Care Syrup Franchise Opportunity in Bangalore

Allergy Care Syrup Franchise Opportunity in Bangalore
Anti Allergic Syrup Export & Manufacturing in Chandigarh

Home/Products /fexofenadine-30mg-5ml-syrup

Fexofozy Suspension

Composition : Fexofenadine (30mg/5ml) Syrup

Dosage Form : Suspension

Packaging Type : Bottle

Packaging : 60ml

Price : ₹129/-

Fexofozy Suspension contains Fexofenadine, a second-generation antihistamine widely used for the management of allergic rhinitis, chronic urticaria, and seasonal allergy symptoms. It provides effective relief from sneezing, itching, runny nose, and watery eyes.

Fexofenadine works by selectively blocking peripheral H1 receptors without crossing the blood-brain barrier, ensuring non-sedating, long-lasting allergy control suitable for daytime use.

The suspension formulation allows easy dosing and improved compliance, especially in pediatric and adolescent patients. Its strong safety profile makes it a preferred choice among physicians for long-term allergy management.

Adding Fexofozy Suspension to your anti-allergic and respiratory portfolio enhances your product range with a fast-moving, season-independent therapy. Its high prescription demand, pediatric suitability, and export readiness make it an excellent option for PCD pharma companies, distributors, and third-party manufacturing partners.


Read More

About the Product

Fexofozy Suspension contains Fexofenadine, a second-generation antihistamine widely used for the management of allergic rhinitis, chronic urticaria, and seasonal allergy symptoms. It provides effective relief from sneezing, itching, runny nose, and watery eyes.

Fexofenadine works by selectively blocking peripheral H1 receptors without crossing the blood-brain barrier, ensuring non-sedating, long-lasting allergy control suitable for daytime use.

The suspension formulation allows easy dosing and improved compliance, especially in pediatric and adolescent patients. Its strong safety profile makes it a preferred choice among physicians for long-term allergy management.

Adding Fexofozy Suspension to your anti-allergic and respiratory portfolio enhances your product range with a fast-moving, season-independent therapy. Its high prescription demand, pediatric suitability, and export readiness make it an excellent option for PCD pharma companies, distributors, and third-party manufacturing partners.


Common side effects may include drowsiness, mild nausea, headache, or gastrointestinal discomfort. Rare but serious side effects include rapid heartbeat, high blood pressure, severe allergic reactions, or liver toxicity. Patients should seek immediate medical attention if severe or unusual symptoms occur.

Coldstuff P Drop is indicated for the relief of cold and flu symptoms, including nasal congestion, runny nose, sneezing, mild pain, and fever associated with upper respiratory tract infections, as prescribed by a healthcare professional.

Coldstuff P Drop should be used exactly as prescribed, with doses carefully measured using the provided dropper. Caution is advised in children with high blood pressure, heart disease, liver disorders, or thyroid problems. Avoid combining with other medications containing similar ingredients.

Store Coldstuff P Drop in a cool, dry place away from direct sunlight. Keep out of reach of children. Shake well before use and follow storage instructions after opening. Do not use beyond the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation